Item Number：UP499326748
| Product Information | |
| Product Name: | TC-S 7010 |
| Chinese Name: | N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺(请以英文为准,中文仅做参考) |
| CAS Number: | 1158838-45-9 |
| Molecular Formula: | C31H31ClFN7O2 |
| Molecular Weight: | 588.08 |
| MDL NO: | MFCD16495816 |
| Standard Purity: | 98+% (UP499326748) |
| Boiling Point: | - |
| Storage: | Sealed in dry,2-8°C (UP499326748) |
| Pubchem ID: | - |
| ACS Number: | - |
| InChIKey： | - |
| Clogp | - |
| English Aliases: | - |
| Chinese Alias: | - |
Inhibitors/Receptor Agonists
Epigenetics
Dna Methyltransferase
Inhibitors/Receptor Agonists
Epigenetics
Tsh Receptor
Inhibitors/Receptor Agonists
Epigenetics
Epigenetic Reader Domain
LY303511
UP903531460154447-38-8
Pazopanib
UP954484494444731-52-6
Axitinib
UP383987322319460-85-0
BMS-345541 Hydrochloride
UP171917544547757-23-3
AMG-900
UP194137462945595-80-2
HM30181
UP973112521849675-66-7
AMG-208
UP9052366751002304-34-8
MLN120B
UP256801813783348-36-7
GNE-477
UP4346063941032754-81-6
Brompheniramine maleate
UP566879003980-71-2
Perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate
UP2394492162101206-48-6
LY2801653 dihydrochloride
UP3230978711206801-37-7
PF-04217903
UP271303822956905-27-4
Benzocaine
UP42146024094-09-7
Yoda 1
UP753583722448947-81-7
MK-8033
UP6579426241001917-37-8
SMI-4a
UP689448202438190-29-5
Dovitinib
UP490857562405169-16-6
Sorafenib tosylate
UP644091340475207-59-1
PHTPP
UP732969774805239-56-9
CYC-116
UP931518742693228-63-6
GSK1070916
UP187568667942918-07-2
mTOR-IN-1
UP3405911521207358-59-5
ENMD-2076
UP797593789934353-76-1
GDC-0810
UP6525656541365888-06-7
NBI-98854
UP702510771171598-74-6
SAR125844
UP4157336471116743-46-4
JNJ-38877605
UP391745046943540-75-8
ACHP Hydrochloride
UP946625927406209-26-5
2,5-Dioxopyrrolidin-1-Yl 3-(2-(2-(1,3-Dioxoisoindolin-2-Yloxy)ethoxy)ethoxy)propanoate
UP1422299282101206-31-7
RI-2
UP9015306071417162-36-7
PK11195
UP11671616485532-75-8
BEZ235 Tosylate
UP4369076581028385-32-1
A 438079 hydrochloride
UP984620916899431-18-6
GDC-0349
UP5994058761207360-89-1
Bitopertin
UP464873541845614-11-1
BMS-777607
UP1452671321025720-94-8
Zotarolimus
UP612452767221877-54-9
GSK1904529A
UP3267917321089283-49-7
AP20187
UP468865875195514-80-8
Ki8751
UP441768513228559-41-9
AG 1296
UP491981993146535-11-7
Necrostatin 2 S-Enantiomer
UP968802750852391-20-9
SEA0400
UP259436261223104-29-8
2,4-Pyrimidinediamine with linker
UP7449068871430089-64-7
IKK-3 Inhibitor
UP747063672862812-98-4
Paliperidone
UP436938591144598-75-4
R1530
UP263011208882531-87-5
Motesanib
UP499561434453562-69-1
trans-Clopenthixol
UP259225591982-24-1
Bay 65-1942 R form
UP546951064758683-21-5
TAK-438 free base
UP161331384881681-00-1
(-)-MK 801 Maleate
UP202786085121917-57-5
TC-S 7010
UP4993267481158838-45-9
